DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
MANUFACTURER: Daiichi Sankyo Company Limited
USAGE: Intravenous
MEDICINE APPROVED BY:
Pharmaceuticals and Medical Devices Agency (PMDA)
Edaravone is a medication developed and marketed by Daiichi Sankyo under the trade name Radicava. It is primarily used for the treatment of a specific neurological condition known as amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig's disease.
